Frederick James Monsma, Jr

Title: Frederick James Monsma, Jr: Innovator in Lipid and Cholesterol Disorders

Introduction

Frederick James Monsma, Jr. is a notable inventor based in Summit, NJ (US). He has made significant contributions to the field of medical science, particularly in the treatment of lipid and cholesterol disorders. With a total of 4 patents to his name, Monsma's work has had a profound impact on healthcare.

Latest Patents

Monsma's latest patents include groundbreaking inventions such as the "Anti-PCSK9 and methods for treating lipid and cholesterol disorders." This invention provides compositions and methods for treating disorders of cholesterol and lipid metabolism through the administration of an anti-PCSK9 antibody or a peptide inhibitor of PCSK9. Another significant patent is "Modulators of the orphan G protein-coupled receptors GPR78 and GPR26." This invention relates to the use of the interaction between the GPR78 polypeptide or the GPR26 polypeptide and their identified ligands and antagonists. It serves as the basis for screening methods to identify agents that modulate the activity of these receptors, which can be used for diagnostic and therapeutic purposes in treating various disorders.

Career Highlights

Monsma has worked with prominent companies in the pharmaceutical industry, including Schering Corporation and Merck Sharp & Dohme Corporation. His experience in these organizations has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Monsma has collaborated with esteemed colleagues such as Joseph A Hedrick and Suke Wang. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Frederick James Monsma, Jr. is a distinguished inventor whose work in lipid and cholesterol disorders has led to significant advancements in medical treatments. His contributions continue to influence the field and improve patient outcomes.